Loss of CDKL5 enhances AKT/ GSK3β signalling [21], conversely inhibition of GSK3β signalling rescues developmental phenotypes in CDD mouse models [65, 66]. This evidence concerns the gene AKT1 and craniodiaphyseal dysplasia.